Abstract
Estrogen has been comprehensively studied as a neuroprotective agent in women, animals, and a variety of in vitro models of neural injury and degeneration. Most data suggest that estrogen can benefit the ischemic brain and reduce cell death. However, recent data from the Women’s Health Initiative have raised concerns about the utility and safety of chronic estrogen use in women. While estrogen is a potent and reproducible neuroprotectant in animals and in vitro, its current administration in women has had unanticipated and paradoxical effects. Nonetheless, estrogen’s diverse actions make it an ideal prototype for developing new neuroprotectants such as selective estrogen receptor modulators (SERMs). SERMs represent a class of drugs with mixed estrogen agonistic and antagonistic activity. Experimental and clinical data suggest a neuroprotective role for SERMs in normal and injured brain. The discrepancy among observational studies, preclinical data, and clinical trials emphasizes the need for further study of the mechanisms leading to the increased incidence of stroke observed in postmenopausal women. Research is still needed to optimize combined or estrogen alone hormone replacement therapy options as well as the prevention/management of cerebrovascular/central nervous system disorders. This review critiques estrogen and SERMs’ neuroprotective potential in experimental and clinical studies of stroke and cerebrovascular disease.
Similar content being viewed by others
References
Writing Group for the Women’s Health Initiative Investigators. (2002). JAMA 288(3), 321–333.
Langer, R. D. (2002). Am. J. Cardiol. 89(Suppl. 12), 36E-46E.
Paganini-Hill, A. (2001). Maturitas 38, 243–261.
Hulley, S., Grady, D., Bush, T., et al. (1998). JAMA 280(7), 605–613.
Grady, D., Herrington, D. Bittner, V., et al. (2002). JAMA 288(1), 49–57.
Viscoli, C. M., Brass, L. M., Kernan, W. N., Sarrel, P. M., Suissa, S., and Horowitz, R. I. (2001). N. Engl. J. Med. 345, 1243–1249.
Murphy, S. J., Traystman, R. J., and Hurn, P. D. (2000). Stroke 31, 1173–1178.
Adams, M. R., Register, T. C., Golden, D. L., Wagner, J. D., and Williams, J. K. (1997). Arterioscler. Thromb. Vasc. Biol. 17, 217–221.
Williams, J. K., Honore, E. K., Washburn, S. A., and Clarkson, T. B. (1994). J. Am. Col.. Cardiol. 24, 1757–1761.
Herrington, D. M., Reboussin, D. M., and Brosnihan, B. (2000). N. Engl. J. Med. 343, 522–529.
Cherry, N., Gilmour, K., Hannaford, P., et al. (2002). Lancet 360(9350), 2001–2008.
Nelson, H. D., Humphrey, L. L., Nygren, P., Teutsch, S. M., and Allan, J. D. (2002). JAMA 288, 872–881.
Alkayed, N. J., Harukuni, I., Kimes, A. S., London, E. D., Traystman, R. J., and Hurn, P. D. (1998). Stroke 29, 159–166.
Carswell, H. V. O., Anderson, N. H., Clark, J. S., et al. (1999). Hypertension 33, 681–685.
Hall, E. D., Pazara, K. E., and Linseman, K. L. (1991). J. Cereb. Blood Flow Metab. 11, 292–298.
Hurn, P. D., Aardelt, A. A., Alkayed, N. J., et al. (2002). In: Pharmacology of cerebral ischemia 2002. Krieglstein, J. (ed.). Medpharm Scientific: Stuttgart, Germany.
Hurn, P. D. and Macrae, I. M. (2000). J. Cereb. Blood Flow Metab. 20, 631–652.
Li, K., Futrell, N., Tovar, J. S., Wang, L. C., Wang, D. Z., and Schultz, L. R. (1996). Stroke 27, 498–503.
Payan, H. M. and Conard, J. R. (1977). Stroke 8, 194–196.
Wise, P. M., Dubal, D. B., Wilson, M. E., Rau, S. W., Bottner, M., and Rosewell, K. L. (2001). Brain Res. Rev. 37, 313–319.
Yamori, Y., Horie, R., Sato, M., and Ohta, K. (1976). Jpn. Heart J. 17(3), 404–406.
Zhang, Y. Q., Shi, J., Rajakumar, G., Day, A. L., and Simpkins, J. W. (1998). Brain Res. 784, 321–324.
Liao, S. L., Chen, W. Y., Kuo, J. S., and Chen, C. J. (2001). Neurosci. Lett. 297, 159–162.
Carswell, H. V. O., Dominiczak, A. F., and Macrae, I. M. (2000). Am. J. Physiol. Heart Circ. Physiol. 278, H290-H294.
Dubal, D. B., Kashon, M. L., Pettigrew, L. C., et al. (1998). J. Cereb. Blood Flow Metab. 18, 1253–1258.
Fukuda, K., Yao, H., Ibayashi, S., Nakahara, T., Uchimura, H., and Fujishima, M. (2000). Stroke 31, 155–160.
Rusa, R., Alkayed, N. J., Crain, B. J., et al. (1999). Stroke 30, 1665–1670.
Simpkins, J. W., Rajakumar, G., Zhang, Y. Q., et al. (1997). J. Neurosurg. 87(5), 724–730.
Wang, Q., Santizo, R., Baughman, V. L., and Pelligrino, D. A. (1999). Stroke 30, 630–637.
Alkayed, N. J., Murphy, S. J., Traystman, R. J., and Hurn, P. D. (2000). Stroke 31, 161–168.
Dhandapani, K. M. and Brann, D. W. (2002). Biol. Reprod. 67, 1379–1385.
Green, P. S. and Simpkins, J. W. (2000). Int. J. Dev. Neurosci. 18, 347–358.
Wise, P. M. and Dubal, D. B. (2000). Biol. Reprod. 63, 982–985.
Harukuni, I., Hurn, P. D., and Crain, B. J. (2001). Brain Res. 900, 137–142.
Hurn, P. D., Littleton-Kearney, M. T., Kirsch, J. R., Dharmaragan, A. M., and Traystman, R. J. (1995). J. Cereb. Blood Flow Metab. 15(4), 666–672.
McCullough, L. D., Alkayed, N. J., Traystman, R. J., Williams, M. J., and Hurn, P. D. (2001). Stroke 32, 796–802.
Watanabe, Y., Littleton-Kearney, M. T., Traystman, R. J., and Hurn, P. D. (2001). Am. J. Physiol. Heart Circ. Physiol. 281(1), H155-H160.
Dubal, D. B., Zhu, H., Yu, J., et al. (2001). Proc. Natl. Acad. Sci. USA 98(4), 1952–1957.
Sampei, K., Goto, S., Alkayed, N. J., et al. (2000). Stroke 31 (3), 738–743.
Sawada, M., Alkayed, N. J., Goto, S., et al. (2000). J. Cereb. Blood Flow Metab. 20(1), 112–118.
Falkenstein, E., Tillman, H. C., Christ, M., Feuring, M., and Wehling, M. (2000). Pharmacol. Rev. 52(4), 513–556.
Linford, N., Wade, C., and Dorsa, D. (2000). J. Neurocytol. 29, 367–374.
Kume-Kick, J. and Rice, M. E. (1998). Brain Res. 803, 105–113.
Mooradian, A. D. (1993). J. Steroid Biochem. Mol. Biol. 45, 509–511.
Ernst, T., Chang, L., Cooray, D., et al. (2002). J. Natl. Cancer Inst. 94(8), 592–597.
Chang, L., Ernst, T., Poland, R. E., and Jenden, D. J. (1996). Life Sci. 58, 2049–2056.
Ganz, P. A., Castellon, S. A., and Silverman, D. H. S. (2002). J. Natl. Cancer Inst. 94(8), 547–549.
Resnick, S. M. and Maki, P. M. (2001). Ann. NY Acad. Sci. 949, 203–214.
Yaffe, K., Krueger, K., Sarkar, S., et al. (2001). N. Engl. J. Med. 344(16), 1207–1213.
Schagen, S. B., van Dam, F. S., Muller, M. J., Boogerd, W., Lindeboom, J., and Bruning, P. F. (1999). Cancer 85, 640–650.
Paganini-Hill, A. and Clark, L. J. (2000). Breast Cancer Res. Treat. 64, 165–176.
Breuer, B. and Anderson, R. (2000). Women Health 31(1), 71–85.
Day, R., Ganz, P. A., Costantino, J. P., Cronin, W. M., Wickerham, D. L., and Fisher, B. (1999). J. Clin. Oncol. 17(9), 2659–2669.
Day, R., Ganz, P. A., and Costantino, J. P. (2001). J. Natl. Cancer Inst. 93, 1615–1623.
Nickelsen, T., Lufkin, E. G., Riggs, B. L., Cox, D. A., and Crook, T. H. (1999). Psychoneuroendocrinology 24, 115–128.
Strickler, R., Stovall, D. W., Merritt, D., Shen, W., Wong, M., and Silfen, S. L. (2000). Obstet. Gynecol. 96(3), 359–365.
Neele, S. J. M., Rombouts, S., Bierlaagh, M. A., Barkhof, F., Scheltens, P., and Netelenbos, J. C. (2001). J. Clin. Endocrinol. Metab. 86(3), 1422–1424.
Barrett-Connor, E., Grady, D., Sashegyi, A., et al. (2002). JAMA 287, 847–857.
Barrett-Connor, E., Grady, D., Sashegyi, A., et al. (2002). American Heart Scientific Sessions, abstract ID 100292.
Littleton-Kearney, M. T., Ostrowski, N. L., Cox, D. A., Rossberg, M. I., and Hurn, P. D. (2002). CNS Drug Rev. 8(3), 309–330.
Zhou, W., Koldzic-Zivanovic, N., Clarke, C. H., et al. (2002). Neuroendocrinology 75, 24–33.
Nilsen, J., Mor, G., and Naftolin, F. (1998). Menopause 5, 211–216.
Silva, I., Mello, L. E., Freymuller, E., Haidar, M. A., and Baracat, E. C. (2000). Neurosci. Lett. 291, 183–186.
McEwen, B. (2002). Recent Prog. Horm. Res. 57, 357–384.
McEwen, B. S., Alves, S. E., Bullock, K., and Weiland, N. G. (1997). Neurology 48, S8-S15.
Cyr, M., Ghribi, O., Thibault, C., Morissette, M., Landry, M., and Di Paolo, T. (2001). Brain Res. Rev. 37, 153–161.
Cyr, M., Morissette, M., Landry, M., and Di Paolo, T. (2001). Neuroreport 12, 535–539.
Cyr, M., Thibault, C., Morissette, M., Landry, M., and Di Paolo, T. (2001). Neuropyschopharmacology 25, 242–257.
Cyr, M., Bosse, R., and Di Paolo, T. (1998). Neuroscience 83, 826–836.
Cyr, M., Landry, M., and Di Paolo, T. (2000). Neuropyschopharmacology 23, 69–78.
Sumner, B. E., Grant, K. E., Rosie, R., Hegele-Hartung, C. H., Fritzemeier, K. H., and Fink, G. (1999). Mol. Brain Res. 73, 119–128.
Ferretti, C., Blengio, M., Ghi, P., Racca, S., Genazzani, E., and Portaleone, P. (1988). Life Sci. 42(24), 2457–2465.
Ferretti, C., Ghi, P., Blengio, M., Gaietta, G., and Genazzani, E. (1989). Pharmacol. Res. 21(1), 93–94.
Bethea, C. L., Mirkes, S. J., Su, A., and Michelson, D. (2002). PNEC 27, 431–445.
McMillan, P. J., LeMaster, A. M., and Dorsa, D. M. (2002). Mol. Brain Res. 103, 140–145.
Wu, X., Glinn, M. A., Ostrawski, N. L., et al. (1999). Brain Res. 847, 98–104.
Baksi, S. N., Redington, T. E., and Hughes, M. J. (1981). Neuropharmacology 20, 1163–1167.
McDermott, J. L., Liu, B., and Dluzen, D. E. (1995). Brain Res. 698, 248–252.
Baksi, S. N., Hughes, M. J., and Lights, K. E. (1985). Neuroscience 14(4), 1053–1059.
Etgen, A. M. and Shamamian, P. (1986). Horm. Behav. 20, 166–180.
McKenna, S. E., Simon, N. G., and Cologer-Clifford, A. (1992). Horm. Behav. 26, 536–544.
Bryant, H. U., Glasebrook, A. L., Yang, N. N., and Sato, M. (1996). J. Bone Miner. Metab. 14, 1–9.
Rossberg, M. I., Murphy, S. J., Traystman, R. J., and Hurn, P. D. (2000). Stroke 31, 3041–3046.
Kimelberg, H. K., Feustel, P. J., Jin, Y., et al. (2000). Neuroreport 11, 2675–2679.
Mehta, S. J., Dhandapani, K. M., Webb, R. C., Mahesh, V. B., and Brann, D. W. (2001). Soc. Neurosci. Abstr. 27, 437.11.
Osuka, K., Feustel, P. J., Mongin, A. A., Tranmer, B. I., and Kimelberg, H. K. (2001). J. Neurochem. 76, 1842–1850.
Phillis, J. W., Song, D., and O’Regan, M. H. (1998). Brain Res. 780, 352–355.
Choi, D. W. (1988). Neuron 1, 623–634.
Shy, H., Malaiyandi, L., and Timiras, P. S. (2000). Int. J. Dev. Neurosci. 18, 289–297.
Hoyt, K. R., McLaughlin, B. A., Higgins, D. S. Jr., and Reynolds, I. J. (2000). J. Pharm. Exp. Ther. 293, 480–486.
Obata, T. (2002). Neurochem. Res. 27(5), 423–431.
Obata, T. and Kubota, S. (2001). Neurosci. Lett. 308, 87–90.
Callier, S., Morissette, M., Grandbois, M., Pelaprat, D., and Di Paolo, T. (2001). Synapse 41, 131–138.
Grandbois, M., Morissette, M., Callier, S., and DiPaolo, R. (2000). Neuroreport 11, 343–346.
Shi, J., Bui, J. D., Yang, S. H., et al. (2001). Stroke 32, 987–992.
Vergouwen, M. D. I., Anderson, R. E., and Meyer, F. B. (2000). Brain Res. 878, 88–97.
Toung, T. J. K., Traystman, R. J., and Hurn, P. D. (1998). Stroke 29, 1666–1670.
Hawk, T., Zhang, Y. Q., Rajakumar, G., Day, A. L., and Simpkins, J. W. (1998). Brain Res. 796(1–2), 296–298.
Dubal, D. B. and Wise, P. M. (2001). Endocrinology 142(1), 43–48.
Saleh, T. M., Cribb, A. E., and Connell, B. J. (2001). Am. J. Physiol. Regul. Integrative Comp. Physiol. 281, R2088-R2095.
Saleh, T. M., Cribb, A. E., and Connell, B. J. (2001b). Am. J. Physiol. Regul. Integrative Comp. Physiol. 281, R1531-R1539.
Culmsee, C., Vedder, H., Ravati, A., et al. (1999). J. Cereb. Blood Flow Metab. 19(11), 1263–1269.
He, Z., He, Y. J., Day, A. L., and Simpkins, J. W. (2002). J. Neurol. Sci. 193, 79–87.
Pelligrino, D. A., Santizo, R., Baughman, V. L., and Want, Q. (1998). Neuroreport 9, 3285–3291.
Horsburgh, K., Macrae, I. M., and Carswell, H. (2002). J. Cereb. Blood Flow Metab. 22, 1189–1195.
Jover, T., Tanaka, H., Calderone, A., et al. (2002). J. Neurosci. 22(6), 2115–2124.
Chen, J., Adachi, N., Liu, K., and Arai, T. (1998). Neuroscience 87(4), 817–822.
Chen, J., Weiren, X., and Jiang, H. (2001). Anesth. Analg. 92, 1520–1523.
Sudo, S., Wen, T. C., Desaki, J., et al. (1997). Neurosci. Res. 29, 345–354.
Davis, S. R. (2002). In: Selective estrogen receptor modulators: research and clinical applications. Manni, A. and Verderame, M. F. (eds.). Humana: Totowa, NJ.
Goldstein, J. S. and Sites, C. K. (2002). Ageing Res. Rev. 1, 17–28.
Labrie, F., Labrie, C., Belanger, A., and Simard, J. (2002). In: Selective estrogen receptor modulators: research and clinical applications. Manni, A. and Verderame, M. F. (eds.). Humana: Totowa, NJ.
Morello, K. C., Wurz, G. T., and DeGregorio, M. W. (2002). Crit. Rev. Oncol./Hematol. 43, 63–76.
Wardley, A. M. (2002). Int. J. Clin. Pract. 56(4), 305–309.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Murphy, S.J., McCullough, L.D., Littleton-Kearney, M.T. et al. Estrogen and selective estrogen receptor modulators. Endocr 21, 17–26 (2003). https://doi.org/10.1385/ENDO:21:1:17
Issue Date:
DOI: https://doi.org/10.1385/ENDO:21:1:17